Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Bill Clinton Scandal - SANITY CHECK -- Ignore unavailable to you. Want to Upgrade?

To: Neocon who wrote (38066)	3/12/1999 7:55:00 AM
From: JBL	Read Replies (1) \| Respond to of 67261

OT : The following info is about AIDS. It sounds important to me, but I have absolutely no idea about the reliability of the source, and can't be certain that it is as significant as I think it is. Xinhua General News Service MARCH 11, 1999, THURSDAY 07:00 Eastern Time wire AIDS cure may have been found: S. A. researchers Xinhua General News Service MARCH 11, 1999, THURSDAY 07:00 Eastern Time Johannesburg, March 11 A cure may have been found for AIDS, researchers at the Medical University of Southern Africa (Medunsa) in Pretoria said Thursday. Announcing the results of the first clinical phase of a new drug developed by an Irish company, the researchers said the ratio of viable HIV viruses had dropped dramatically in patients tested. Their balance of white blood cells, attacked by the virus, was also restored. Human Immunodeficiency Virus or HIV leads to full-blown AIDS or Acquired Immunodeficiency Syndrome. "After treatment only one trial patient still showed signs of living virus in his blood," co-director of the study, Professor Wimpie du Plooy, told reporters. The drug known as Inactivin showed no negative side effects. Although the long-term effects were not known, du Plooy said: "We may have found a cure for AIDS." Medunsa tested the drug at the request of Irish company Colthurst Ltd., with the full approval of the Medicines Control Council. Du Plooy said while the drug did not remove all viral cells, it would be possible to control the AIDS disease to such an extent that patients would no longer be terminal. The drug stops the HIV virus from replicating. Du Plooy said Inactivin, a single drug treatment, would be comparatively inexpensive. Asked whether it could be on the market by the end of the year, he said: "There is a chance." Medunsa researchers administered small doses of Inactivin to a small group of HIV-positive individuals in August last year. A second group received larger doses in November. "In both sets of tests, consisting of five consecutive days of drug administration, CD4 (white blood cells) counts increased... and the number of HIV virus present in circulating while blood cells decreased to almost zero." The one trial patient still showing signs of living hiv virus in his blood had a ratio of only one viable HIV virus per 1,000,000 white blood cells, du Plooy said.